Anti-p14ARF Monoclonal Antibody (Clone: 4C6/4), Clone: [4C6/4], Mouse

Artikelnummer: ABI-36-2028
Artikelname: Anti-p14ARF Monoclonal Antibody (Clone: 4C6/4), Clone: [4C6/4], Mouse
Artikelnummer: ABI-36-2028
Hersteller Artikelnummer: 36-2028
Alternativnummer: ABI-36-2028-100UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: FACS, IF, IHC, WB
Spezies Reaktivität: Human, Rat
Immunogen: Recombinant full-length human p14 ARF protein
Alternative Synonym: ARF, CDK4 inhibitor p16 INK4, CDK4I, CDKN2, CDKN2A, Cell cycle negative regulator beta, CMM2, Cyclin dependent kinase 4 inhibitor A, Cyclin dependent kinase inhibitor 2A, INK4, INK4a, Melanoma p16 inhibits CDK4, MLM, MTS 1, MTS1, Multiple tumor suppressor 1, p14, p16, p16 INK4a, p16INK4a, p19, P19AR
The progression of cells through the cell cycle is regulated by a family of proteins designated cyclin-dependent kinases (Cdks). Sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. Multiple proteins are encoded by the tumor suppressor gene CDKN2A (MTS1/ p16INK4a) via translation of alternate reading frames, resulting in the pro- duction of the p19 ARF protein in mice and the p14 ARF protein in humans. p14 ARF induces an increase in MDM2 and p21 levels and leads to cell cycle arrest in both G1 and G2/M. p14 ARF is negatively regulated by p53 and is known to bind directly to MDM2. CDKN2A also encodes the mitotic protein p16, which binds to and inhibits the Cdk4/cyclin D complex.
Klonalität: Monoclonal
Klon-Bezeichnung: [4C6/4]
NCBI: 1029
UniProt: P42771
Application Verdünnung: Flow Cytometry (1-2ug/million cells), Immunofluorescence (1-2ug/ml), Western Blot (1-2ug/ml), Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA,